Company Data

Akari Therapeutics Plc

Ticker
AKTX
Current Price
$0.97 -8.06%
Market Cap
$24.0M
Price Target
Refer to Report
Volume
30.0K
52wk Range
$0.9 - $4.4
Advanced Market Data

Overview

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system for the treatment of rare and orphan diseases. Its main product candidate includes Coversin, Coversin long acting and Coversin dual action. The firm earns majority of its revenues from United Kingdom. It operates mainly in United States and United Kingdom.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy